Hi there,

If you think Democracy Now!’s reporting is a critical line of defense against war, climate catastrophe and authoritarianism, please make your donation of $10 or more right now. Today, a generous donor will DOUBLE your donation, which means it’ll go 2x as far to support our independent journalism. Democracy Now! is funded by you, and that’s why we’re counting on your donation to keep us going strong. Please give today. Every dollar makes a difference—in fact, gets doubled! Thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Dr. Irwin Schatz, Lone Critic of Tuskegee Syphilis Study, Dies at 83

HeadlineApr 20, 2015

And Dr. Irwin Schatz, who became a lone critic of the now-notorious Tuskegee syphilis study years before it was exposed in the press, has died at the age of 83. For four decades until 1972, the U.S. government studied the long-term effects of untreated syphilis on poor, black men. After reading of the study in a medical journal in 1964, Schatz wrote, “I am utterly astounded by the fact that physicians allow patients with potentially fatal disease to remain untreated when effective therapy is available.” But a study co-author dismissed his letter, saying it was the first of its kind they had received. Schatz died of cancer at home in Hawaii.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top